Latest

Multiple Sclerosis

Featured Genetics Neurology Neuroscience

·November 27, 2023·6 min read

Pioneering Stem Cell Therapy for Progressive Multiple Sclerosis Shows Promise

An international team has conducted a groundbreaking study on stem cell therapy for progressive multiple sclerosis (MS). The therapy, involving the injection of neural stem cells into patients' brains, was found to be safe and potentially effective in preventing further brain damage.

Featured Neurology Neuroscience

·November 6, 2023·6 min read

Biomarker in Blood Predicts Multiple Sclerosis Progression 1 to 2 Years in Advance

Researchers has found that elevated levels of NfL in the blood of multiple sclerosis (MS) patients could signal worsening disability within the next one to two years. This first-of-its-kind study pinpoints a crucial timeframe for potential interventions.

Featured Neurology Neuroscience

·November 3, 2023·5 min read

Is a Common Bacteria a Trigger For Multiple Sclerosis?

Researchers have discovered a potential link between the microbe C. perfringens and the progression of multiple sclerosis (MS). The study suggests that an epsilon toxin from the bacteria might degrade the blood-brain barrier, initiating the debilitating symptoms of MS.

Featured Neurology Neuroscience

·September 3, 2023·5 min read

Multiple Sclerosis Drug Shows Promise as New Alzheimer’s Therapy

A groundbreaking revealed that ponesimod, a drug originally used to treat multiple sclerosis, shows potential in treating Alzheimer’s disease. Researchers found that the medication reduces neuroinflammation, a critical factor in Alzheimer’s progression.

Featured Genetics Neurology Neuroscience

·August 24, 2023·5 min read

Unlocking Myelin Regeneration

Researchers revealed a pivotal mechanism in myelin repair and regeneration, focusing on the Daam2 protein and CK2α kinase. Myelin, critical for efficient neurotransmission, when damaged leads to serious neurological diseases.

Featured Neurology Neuroscience

·July 27, 2023·4 min read

Gut Microbiome Triggers Key Cells Linked to Multiple Sclerosis

Researchers made a groundbreaking discovery about the role of the gut microbiome in activating T cells, which contribute to the development of Multiple Sclerosis (MS). Using advanced imaging techniques in a mouse model, the team tracked how the gut microbiome activated these cells live for the first time.

Featured Neurology Neuroscience

·July 11, 2023·5 min read

Brain Barrier Inflammation: A Stealthy Contributor to Multiple Sclerosis

A study in mice reveals that inflammation in the brain's barrier, or the meninges, may seep into grey matter, fostering the progression of multiple sclerosis (MS). Utilizing novel methods, the study provides evidence of a gradient of immune genes and inflammatory markers transitioning from the meninges into the brain tissue.

Featured Genetics Neurology Neuroscience

·June 28, 2023·5 min read

Genetic Variant Linked to Faster Progression of Multiple Sclerosis Found

A new study involving over 22,000 people with Multiple Sclerosis (MS) has identified a genetic variant associated with the disease's faster progression. The research discovered a genetic variant that significantly affects disease severity.

Featured Neuroscience Neuroscience Videos

·June 18, 2023·3 min read

Top 5 Breakthroughs From Neuroscience News This Week: June 18, 2023

Dive into this week's hottest neuroscience discoveries from Neuroscience News. Uncover how our survival influences visual perception, delve into the role of interoception in self-awareness, and see how an antihistamine offers hope for myelin repair in Multiple Sclerosis.

Featured Neurology Neuroscience

·June 17, 2023·3 min read

Pregnancy Hormone Estriol May Reverse Myelin Damage in Multiple Sclerosis

Treating a mouse model of multiple sclerosis (MS) with the pregnancy hormone estriol could reverse myelin breakdown in the brain's cortex, a primary area affected in MS. MS results in inflammation that damages the myelin coating around nerve fibers in the brain's cortex, leading to disability worsening.

Featured Neurology Neuroscience

·June 13, 2023·5 min read

Antihistamine Sparks Hope for Myelin Repair in Multiple Sclerosis

A new study paves the way for potential treatments for Multiple Sclerosis (MS) by identifying the OTC antihistamine, clemastine, as an effective drug for brain repair. Utilizing a newly-developed MRI scan technique, scientists were able to observe and measure the impact of clemastine on brain myelin levels.

Featured Neurology Neuroscience

·May 25, 2023·6 min read

Loosely Wrapped Myelin Marks Early Stages of Multiple Sclerosis, Even Before Inflammation

Structural abnormalities in white matter, even before the onset of inflammation, may serve as a new therapeutic target for multiple sclerosis (MS). The study, focusing on 'normal-appearing white matter', identified early changes in myelin, an insulating substance around nerve fibers.

1 2 3 … 35

Multiple Sclerosis

Pioneering Stem Cell Therapy for Progressive Multiple Sclerosis Shows Promise

Biomarker in Blood Predicts Multiple Sclerosis Progression 1 to 2 Years in Advance

Is a Common Bacteria a Trigger For Multiple Sclerosis?

Multiple Sclerosis Drug Shows Promise as New Alzheimer’s Therapy

Unlocking Myelin Regeneration

Gut Microbiome Triggers Key Cells Linked to Multiple Sclerosis

Brain Barrier Inflammation: A Stealthy Contributor to Multiple Sclerosis

Genetic Variant Linked to Faster Progression of Multiple Sclerosis Found

Top 5 Breakthroughs From Neuroscience News This Week: June 18, 2023

Pregnancy Hormone Estriol May Reverse Myelin Damage in Multiple Sclerosis

Antihistamine Sparks Hope for Myelin Repair in Multiple Sclerosis

Loosely Wrapped Myelin Marks Early Stages of Multiple Sclerosis, Even Before Inflammation

Heartbeat’s Influence on Brain Activity

Reshaping the OCD Brain: How Therapy Alters Neural Connectivity

Persistent Brain Repair Signals in Ex-NFL Players

Innovative Fiber to Tackle Alzheimer’s Developed

Subscribe